We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
(+5.9%)
Cap. Flow
-$501M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$417M |
| 2 |
Meta Platforms (Facebook)
META
|
+$383M |
| 3 |
Amazon
AMZN
|
+$308M |
| 4 |
Microsoft
MSFT
|
+$293M |
| 5 |
GE Aerospace
GE
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$312M |
| 2 |
Bank of America
BAC
|
+$292M |
| 3 |
ExxonMobil
XOM
|
+$274M |
| 4 |
lululemon athletica
LULU
|
+$238M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.05% |
| 2 | Technology | 14.35% |
| 3 | Consumer Discretionary | 13.97% |
| 4 | Financials | 9.9% |
| 5 | Industrials | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NXGN
2026
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $559K | ﹤0.01% |
+32,103
| New | +$577K |
|
|
ORLA
2027
Orla Mining
ORLA
$3.36B
| $558K | ﹤0.01% |
+117,400
| New | +$501K |
|
2028
CALL
3M
MMM
$91.8B
| $557K | ﹤0.01% |
6,339
-8,850
| -58% | -$835K |
|
2029
Global X Cloud Computing ETF
CLOU
$236M
| $557K | ﹤0.01% |
30,338
+19,438
| +178% | +$339K |
|
|
ROCL
2030
DELISTED
Roth CH Acquisition V Co. Common Stock
ROCL
| $556K | ﹤0.01% |
53,910
| – | – |
|
2031
Itron
ITRI
$4.48B
| $552K | ﹤0.01% |
9,950
+4,335
| +77% | +$239K |
|
2032
Ivanhoe Electric
IE
$1.38B
| $551K | ﹤0.01% |
+45,343
| New | +$608K |
|
2033
Oil-Dri
ODC
$1.43B
| $550K | ﹤0.01% |
+26,424
| New | +$489K |
|
|
TRST
2034
Trustco Bank Corp NY
TRST
$953M
| $550K | ﹤0.01% |
+17,208
| New | +$617K |
|
2035
American Resources Corp
AREC
$183M
| $545K | ﹤0.01% |
363,230
-192,398
| -35% | -$288K |
|
2036
BellRing Brands
BRBR
$1.55B
| $540K | ﹤0.01% |
+15,879
| New | +$469K |
|
|
TMCWW
2037
CALL
TMC The Metals Company Warrants
TMCWW
$474K
| $540K | ﹤0.01% |
650,000
| – | – |
|
2038
Alerus Financial
ALRS
$828M
| $538K | ﹤0.01% |
+33,526
| New | +$664K |
|
2039
Puma Biotechnology
PBYI
$398M
| $537K | ﹤0.01% |
173,816
-147,441
| -46% | -$556K |
|
|
MSPR
2040
DELISTED
MSP Recovery Inc
MSPR
| $537K | ﹤0.01% |
144
| – | – |
|
2041
Applied Optoelectronics
AAOI
$6.14B
| $537K | ﹤0.01% |
242,773
-32,284
| -12% | -$79.1K |
|
2042
Artivion
AORT
$1.34B
| $537K | ﹤0.01% |
+40,955
| New | +$523K |
|
|
TE
2043
T1 Energy
TE
$1.04B
| $532K | ﹤0.01% |
59,835
-5,257
| -8% | -$45.7K |
|
|
KBAL
2044
DELISTED
Kimball International
KBAL
| $532K | ﹤0.01% |
42,883
+1,205
| +3% | +$10.4K |
|
2045
LegalZoom.com
LZ
$1.45B
| $532K | ﹤0.01% |
+56,681
| New | +$480K |
|
2046
AnaptysBio
ANAB
$1.54B
| $531K | ﹤0.01% |
+24,397
| New | +$593K |
|
2047
MarineMax
HZO
$748M
| $527K | ﹤0.01% |
+18,342
| New | +$577K |
|
2048
Westrock Coffee
WEST
$798M
| $527K | ﹤0.01% |
+43,019
| New | +$530K |
|
|
CHEA
2049
DELISTED
Chenghe Acquisition Co. Class A Ordinary Share
CHEA
| $525K | ﹤0.01% |
49,998
| – | – |
|
2050
Getty Images
GETY
$159M
| $525K | ﹤0.01% |
+103,148
| New | +$573K |
|
Similar funds
Marshall Wace's Q1 2023 Portfolio in Review
As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
- Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
- Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
- Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
- Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
- Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
- Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.
Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.